State Street Corp Alkermes Plc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Alkermes Plc. stock. As of the latest transaction made, State Street Corp holds 8,814,975 shares of ALKS stock, worth $311 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,814,975

Previous 9,185,392 4.03%

Holding current value

$311 Million

Previous $257 Million 1.39%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$25.7 - $31.46 $9.52 Million - $11.7 Million	-370,417 Reduced 4.03%	8,814,975 $254 Million
Q3 2024 Nov 14, 2024	SELL	$23.01 - $28.55 $682,614 - $846,964	-29,666 Reduced 0.32%	9,185,392 $257 Million
Q2 2024 Aug 14, 2024	BUY	$23.21 - $27.24 $4.9 Million - $5.75 Million	211,145 Added 2.35%	9,215,058 $222 Million
Q1 2024 May 15, 2024	SELL	$26.4 - $32.56 $9.22 Million - $11.4 Million	-349,057 Reduced 3.73%	9,003,913 $244 Million
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $76.2 Million - $93.5 Million	3,261,476 Added 53.54%	9,352,970 $259 Million
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $5.47 Million - $6.43 Million	201,191 Added 3.42%	6,091,494 $171 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $2.93 Million - $3.47 Million	103,262 Added 1.78%	5,890,303 $184 Million
Q1 2023 May 15, 2023	SELL	$25.31 - $29.02 $17 Million - $19.5 Million	-672,366 Reduced 10.41%	5,787,041 $163 Million
Q4 2022 Feb 14, 2023	SELL	$21.94 - $26.24 $171,000 - $204,514	-7,794 Reduced 0.12%	6,459,407 $169 Million
Q3 2022 Nov 15, 2022	BUY	$22.0 - $31.87 $12.2 Million - $17.7 Million	556,097 Added 9.41%	6,467,201 $144 Million
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $3.46 Million - $4.01 Million	131,205 Added 2.27%	5,911,104 $176 Million
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $1.97 Million - $2.39 Million	85,459 Added 1.5%	5,779,899 $152 Million
Q4 2021 Feb 14, 2022	BUY	$21.47 - $32.08 $16.6 Million - $24.8 Million	772,964 Added 15.71%	5,694,440 $132 Million
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $767,938 - $1.06 Million	-32,860 Reduced 0.66%	4,921,476 $152 Million
Q2 2021 Aug 16, 2021	BUY	$18.78 - $25.15 $8.63 Million - $11.6 Million	459,735 Added 10.23%	4,954,336 $121 Million
Q1 2021 May 17, 2021	SELL	$18.21 - $23.2 $6.7 Million - $8.53 Million	-367,827 Reduced 7.56%	4,494,601 $84 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $22.1 $2.52 Million - $3.62 Million	163,689 Added 3.48%	4,862,428 $97 Million
Q3 2020 Nov 10, 2020	SELL	$16.16 - $20.66 $8.24 Million - $10.5 Million	-509,926 Reduced 9.79%	4,698,739 $77.9 Million
Q2 2020 Aug 14, 2020	BUY	$13.31 - $19.41 $6.27 Million - $9.14 Million	470,866 Added 9.94%	5,208,665 $101 Million
Q1 2020 May 11, 2020	BUY	$13.06 - $21.24 $61.9 Million - $101 Million	4,737,799 New	4,737,799 $68.3 Million

Others Institutions Holding ALKS

# of Institutions

375

Shares Held

173M

Call Options Held

231K

Put Options Held

158K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.8B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Alkermes Plc. Transaction History